Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2525 (LINC02525)

Target
LINC02525
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-protein coding RNA (LINC RNA)
01

Overview

LINC02525 (Long intergenic non-protein coding RNA 2525) is a long non-coding RNA gene located on chromosome 6p25.2. It is highly expressed in certain cancers, notably neuroblastoma and glioma. Experimental studies demonstrate that LINC02525 can enhance tumor cell migration and invasion, influence cell proliferation, and regulate apoptosis, likely through interaction with cellular proteins such as ribosomal protein RPL35. LINC02525 and related lncRNAs are emerging as important players in cancer progression and are under exploration as potential therapeutic targets and biomarkers in oncology. No classical small molecule or biologic drugs currently target LINC02525 directly, but ongoing research may identify targeted therapies or RNA-based interventions in the future.

Other names
TP53LC14lncNB1RP1-40E16.9lncRNA highly expressed in neuroblastoma 1lincNB1
02

Mechanism of action

Not applicable for classical small molecules; experimental evidence suggests it acts by binding/interacting with specific proteins such as RPL35, influencing gene expression and tumor cell behaviors

03

Biological functions

Regulation of cell proliferationRegulation of apoptosis/cell deathInvolvement in neuronal differentiationPromotion of tumor cell migration and invasion (notably glioma)Interacts with ribosomal protein RPL35 to promote tumorigenesis
04

Disease associations

Cancer (implicated in neuroblastoma, glioma and possibly other cancers)Potential role in central nervous system tumors
05

Safety considerations

No specific safety concerns or therapeutic challenges identified; as with other lncRNAs, targeting specificity and delivery in vivo may be concerns in therapeutic development
06

Biomarkers

May be a biomarker for high-risk neuroblastoma and glioma tumor progression

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2525 (LINC02525).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2525 (LINC02525).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call